Taskén K - Search Results

1

Phosphodiesterases as targets for modulating T-cell responses.

Bjørgo E, Moltu K, Taskén K. Bjørgo E, et al. Among authors: tasken k. Handb Exp Pharmacol. 2011;(204):345-63. doi: 10.1007/978-3-642-17969-3_15. Handb Exp Pharmacol. 2011. PMID: 21695648 Review.

2

Protein kinase A intersects SRC signaling in membrane microdomains.

Abrahamsen H, Vang T, Taskén K. Abrahamsen H, et al. Among authors: tasken k. J Biol Chem. 2003 May 9;278(19):17170-7. doi: 10.1074/jbc.M211426200. Epub 2003 Feb 26. J Biol Chem. 2003. PMID: 12606547 Free article.

3

TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.

Abrahamsen H, Baillie G, Ngai J, Vang T, Nika K, Ruppelt A, Mustelin T, Zaccolo M, Houslay M, Taskén K. Abrahamsen H, et al. Among authors: tasken k. J Immunol. 2004 Oct 15;173(8):4847-58. doi: 10.4049/jimmunol.173.8.4847. J Immunol. 2004. PMID: 15470025

4

Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts.

Tasken K, Ruppelt A. Tasken K, et al. Front Biosci. 2006 Sep 1;11:2929-39. doi: 10.2741/2022. Front Biosci. 2006. PMID: 16720365 Review.

5

The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages.

Bryn T, Mahic M, Enserink JM, Schwede F, Aandahl EM, Taskén K. Bryn T, et al. Among authors: tasken k. J Immunol. 2006 Jun 15;176(12):7361-70. doi: 10.4049/jimmunol.176.12.7361. J Immunol. 2006. PMID: 16751380

6

Reduced PDE4 expression and activity contributes to enhanced catecholamine-induced cAMP accumulation in adipocytes from FOXC2 transgenic mice.

Grønning LM, Baillie GS, Cederberg A, Lynch MJ, Houslay MD, Enerbäck S, Taskén K. Grønning LM, et al. Among authors: tasken k. FEBS Lett. 2006 Jul 24;580(17):4126-30. doi: 10.1016/j.febslet.2006.06.058. Epub 2006 Jun 30. FEBS Lett. 2006. PMID: 16828089 Free article.

7

Role of cAMP phosphodiesterase 4 in regulation of T-cell function.

Bjørgo E, Taskén K. Bjørgo E, et al. Among authors: tasken k. Crit Rev Immunol. 2006;26(5):443-51. doi: 10.1615/critrevimmunol.v26.i5.40. Crit Rev Immunol. 2006. PMID: 17341187 Review.

8

Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin.

Ruppelt A, Mosenden R, Grönholm M, Aandahl EM, Tobin D, Carlson CR, Abrahamsen H, Herberg FW, Carpén O, Taskén K. Ruppelt A, et al. Among authors: tasken k. J Immunol. 2007 Oct 15;179(8):5159-68. doi: 10.4049/jimmunol.179.8.5159. J Immunol. 2007. PMID: 17911601

9

Role for the cAMP-protein kinase A signaling pathway in suppression of antitumor immune responses by regulatory T cells.

Yaqub S, Taskén K. Yaqub S, et al. Among authors: tasken k. Crit Rev Oncog. 2008;14(1):57-77. doi: 10.1615/critrevoncog.v14.i1.40. Crit Rev Oncog. 2008. PMID: 19105570

10

The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP.

Stokka AJ, Mosenden R, Ruppelt A, Lygren B, Taskén K. Stokka AJ, et al. Among authors: tasken k. Biochem J. 2009 Dec 23;425(2):381-8. doi: 10.1042/BJ20091136. Biochem J. 2009. PMID: 19857202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters